In Review: Late Friday afternoon, Senator Rob Hutton (R) introduced legislation relating to PBM transparency to the payer. PCMA sent the draft to member companies for feedback. Up Next: The deadline for co-sponsorship is November 14. After this date, the
In Review: Last week, SB 492, relating to coverage of non-opioid drugs, was given a public hearing in the Senate Committee on Mental Health, Substance Abuse Prevention, and Children and Families. PCMA provided testimony in opposition to the bill. As
In Review: Senate Bill 492, relating to coverage of nonopioid drug alternatives for the treatment and management of pain, will receive a public hearing this Wednesday in the Senate Mental Health, Substance Abuse Prevention, Children and Families Committee. PCMA will be submitting
In Review: PCMA continues to meet with Republican Senators and share our concerns with the omnibus anti-PBM bill, SB 203. PCMA counsel has met with two Republican Senators, who have both indicated that they have ‘no’ votes and do not
In Review: On Tuesday, August 19, an amendment was introduced to the PBM bill, SB 203. Among other things, the bill removed the dispensing fee from the bill, but added other unfavorable language, including a provision that prohibits PBMs from
In Review: Governor Tony Evers (D) announced that he will not seek a third term for Governor. This will create an open seat and generate multiple candidates from each party. Governor Evers, during his tenure, introduced PBM legislation policy in all
In Review: The Senate Health Committee held a public hearing on AB 173/SB 203, an anti-PBM bill. PCMA, other stakeholders within the industry, and business groups, including the state chamber, testified in opposition to the bill. Up Next: It is
In Review: The Senate Health Committee is holding a public hearing on the anti-PBM, AB 173/SB 203. PCMA and other stakeholders within the industry will be testifying in opposition, as will the state chamber and other business entities. If you
In Review: PCMA counsel continues to meet with the Senate Health Committee members leading up to the public hearing taking place on May 28th, on the anti-PBM bill Assembly Bill 173 / Senate Bill 203. The broader stakeholder group met
In Review: PCMA was successful in getting 18 policy items related to PBMs removed from the governor’s budget proposal. Examples of the policies that are now eliminated include PBM fiduciary mandate, gold carding provisions, and a ban on copay accumulators.
